← Back to Search

Exparel for Urinary Tract Infection

Phase 4
Waitlist Available
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing urologic surgery.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days postoperatively
Awards & highlights

Study Summary

This trial looks at whether a new painkiller is effective for people undergoing urologic surgeries.

Eligible Conditions
  • Urinary Tract Infection

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Length of Hospital Stay and readmission
Postoperative complications
Postoperative pain assessment
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExparelExperimental Treatment1 Intervention
This arm will receive intraoperative local Liposomal Bupivacaine injection (Exparel) at the port placement site.
Group II: MarcaineActive Control1 Intervention
This group will receive will local bupivacaine HCl (Marcaine) injection at the port placement site.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,848 Total Patients Enrolled
Mohamed Keheila, MDStudy DirectorLoma Linda University Medical Center
2 Previous Clinical Trials
15 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Gynecologic OncologyJournal
Ultrasound Guided Subcostal Transversus Abdominis Plane (TAP) Infiltration with Liposomal Bupivacaine for Patients Undergoing Robotic Assisted Hysterectomy: A Prospective Randomized Controlled Study
Hutchins, Jacob, Daniel Delaney, Rachel Isaksson Vogel, Rahel G. Ghebre, Levi S. Downs Jr., Linda Carson, Sally Mullany, Deanna Teoh, and Melissa A. Geller. 2015. “Ultrasound Guided Subcostal Transversus Abdominis Plane (TAP) Infiltration with Liposomal Bupivacaine for Patients Undergoing Robotic Assisted Hysterectomy: A Prospective Randomized Controlled Study”. Gynecologic Oncology. Elsevier BV. doi:10.1016/j.ygyno.2015.06.008.
Pharmacotherapy: The Journal of Human Pharmacology and Drug TherapyJournal
Impact of Liposomal Bupivacaine Administration on Postoperative Pain in Patients Undergoing Total Knee Replacement
White, Sarah, Cathy Vaughan, Doug Raiff, William Eward, and Michael Bolognesi. 2015. “Impact of Liposomal Bupivacaine Administration on Postoperative Pain in Patients Undergoing Total Knee Replacement”. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Wiley. doi:10.1002/phar.1587.
Annals of Surgical OncologyJournal
Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction
Abdelsattar, Jad M., Judy C. Boughey, Aodhnait S. Fahy, James W. Jakub, David R. Farley, Tina J. Hieken, Amy C. Degnim, et al.. 2015. “Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction”. Annals of Surgical Oncology. Springer Science and Business Media LLC. doi:10.1245/s10434-015-4833-4.
Gynecologic OncologyJournal
Ultrasound Guided Subcostal Transversus Abdominis Plane (TAP) Infiltration with Liposomal Bupivacaine for Patients Undergoing Robotic Assisted Hysterectomy: A Prospective Randomized Controlled Study
Hutchins, Jacob, Daniel Delaney, Rachel Isaksson Vogel, Rahel G. Ghebre, Levi S. Downs Jr., Linda Carson, Sally Mullany, Deanna Teoh, and Melissa A. Geller. 2015. “Ultrasound Guided Subcostal Transversus Abdominis Plane (TAP) Infiltration with Liposomal Bupivacaine for Patients Undergoing Robotic Assisted Hysterectomy: A Prospective Randomized Controlled Study”. Gynecologic Oncology. Elsevier BV. doi:10.1016/j.ygyno.2015.06.008.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top